Skip to content

To Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy

Randomized, Double- Blind, Controlled Trial to Evaluate the Effect of Wound Infiltration With Bupivacaine for Post-operative Pain Relief After Laparoscopic Cholecystectomy

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03958513
Enrollment
58
Registered
2019-05-22
Start date
2019-01-01
Completion date
2019-07-31
Last updated
2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Pain

Brief summary

To evaluate the effect of wound infiltration with 0.25% Bupivacaine in laparoscopic cholecystectomy in terms of pain severity, patient satisfaction level, quality of life, hospital stay and return to job and normal activities.

Interventions

DRUGBupivacaine

1.5 ml 0.25% bupivacaine for 1 inch incision will be given before closure of ports in patients undergoing laparoscopic cholecystectomy

DRUG0.9% normal saline

1.5 ml 0.9% NACl for 1 inch incision will be given before closure of ports in patients undergoing laparoscopic cholecystectomy

Sponsors

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients scheduled to undergo laparoscopic cholecystectomy under general anesthesia at department of surgery and department of hepatobiliary system, BSMMU * Patients who are eligible according to ASA Ⅰ -Ⅱ * Female or male, age ≥18 years * Patients who are scheduled for same anesthetic technique and surgical procedure for laparoscopic cholecystectomy * Discharge of patient between 12 hour to 36 hour after performing procedure * Patients given consent for enrollment in study

Exclusion criteria

* Patients known to be allergic to certain recommended drugs * If patients have history of psychiatric illness * Patients on chronic analgesic therapy for any other indication * Patients who are scheduled for different anesthetic technique and surgical procedure for laparoscopic cholecystectomy * Duration of surgery more than 1 hour * Patients undergoing laparoscopic cholecystectomy for complex gallbladder disease such as incidental gallbladder pancreatitis, gallstone pancreatitis, cholecystoduodenal fistula, mirizzi syndrome * Special population group such as children, pregnant woman, patients with cirrhosis, diabetics * Duration of operative procedure more than 1 hour

Design outcomes

Primary

MeasureTime frameDescription
Post-operative pain: VAS12 hoursPost-operative pain in visual analog scale ranging 0 to100
Post-operative pain: rating scale12 HOURSPost-operative pain in numerical rating scale ranging 0 to 4

Secondary

MeasureTime frameDescription
Pain during hospital discharge: VAS3-5daysvisual analog scale score during hospital discharge rangibg 0-100
Patient Satisfaction Level: questionnaire24 hourPatient Satisfaction Level is measured with revised american pain society outcome questionnaire. 12 questions are present.
Assesment of quality of life: index15th and 30th post-operative dayQuality of life is measured with gastrointestinal quality of life index. there are 36 questions . it will measure quality of life after surgery.
Time taken to return to job and normal activities15-30 days
Hospital stay3-5 daysTime frame for hospital discharge

Countries

Bangladesh

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026